Literature DB >> 1974178

Autoreactive cytotoxicity in HIV-infected individuals.

D Israël-Biet1, A Venet, K Beldjord, J M Andrieu, P Even.   

Abstract

A possible role for autoimmunity in the pathogenesis of HIV infection has been suggested, based upon the certain degree of homology shared by HIV gp41 and MHC class II molecules. A number of humoral markers of autoimmunity have since been found in seropositive subjects. We have evaluated the cellular autoreactive response in HIV-infected individuals. Our study demonstrates the existence of a cytolytic activity, present in seropositive but not in seronegative subjects. This activity is mediated by CD3+ T cells, which only occasionally express the CD8 or the CD4 surface markers. Effector cells do not appear to exert their activity in a MHC-restricted fashion, since allogeneic target cells could also be killed, recovered from allogeneic seropositive as well as from seronegative subjects. Several types of target cells were lysed: T cell blasts and Epstein-Barr virus (EBV) transformed B cells, suggesting that the target antigen is common to at least these two cell types. The fact that cells from seronegative individuals were lysed argues against the recognition of an HIV-specific antigen. The nature of the target determinants and the identity of the effector cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974178      PMCID: PMC1535018          DOI: 10.1111/j.1365-2249.1990.tb05285.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  Induction of expression of HIV in latently or chronically infected cells.

Authors:  Z F Rosenberg; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1989-02       Impact factor: 2.205

2.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

4.  An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.

Authors:  R B Stricker; T M McHugh; D J Moody; W J Morrow; D P Stites; M A Shuman; J A Levy
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

5.  Target platelet antigen in homosexual men with immune thrombocytopenia.

Authors:  R B Stricker; D I Abrams; L Corash; M A Shuman
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

6.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.

Authors:  J S McDougal; A Mawle; S P Cort; J K Nicholson; G D Cross; J A Scheppler-Campbell; D Hicks; J Sligh
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  Cellular targets of antilymphocyte antibodies in AIDS and LAS.

Authors:  R H Tomar; P A John; A K Hennig; B Kloster
Journal:  Clin Immunol Immunopathol       Date:  1985-10

8.  Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis.

Authors:  E M Janis; S H Kaufmann; R H Schwartz; D M Pardoll
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

9.  T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection.

Authors:  J E Morgan; C B Daul; R D de Shazo; W A Andes; N H Hyslop
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

10.  Human TCR-gamma+/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion.

Authors:  D Kozbor; G Trinchieri; D S Monos; M Isobe; G Russo; J A Haney; C Zmijewski; C M Croce
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  6 in total

1.  HIV induces modulation of functionally important cellular antigens.

Authors:  M Wrightham; A Schimpf; T H Pennington; F Walker; H F Sewell
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.

Authors:  S Kottilil; J Gamberg; I Bowmer; J Trahey; C Howley; M Gallant; M Grant
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

3.  Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.

Authors:  M D Grant; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

4.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

5.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Authors:  J H Vingerhoets; G L Vanham; L L Kestens; G G Penne; R L Colebunders; M J Vandenbruaene; J Goeman; P L Gigase; M De Boer; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 6.  Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention.

Authors:  H Atlan; M J Gersten; P L Salk; J Salk
Journal:  Res Immunol       Date:  1994 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.